A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug resistance of breast cancer ...
Apr 8, 2024
0
7
Combining the KRAS G12C inhibitor adagrasib with the anti-EGFR antibody cetuximab demonstrated promising anti-tumor effects in patients with KRAS G12C-mutated metastatic colorectal cancer (CRC), according to pooled results ...
Apr 8, 2024
0
2
In a new study published in Molecular Oncology, researchers have discovered a novel mechanism to enhance the body's immune response to tumors.
Apr 3, 2024
0
0
A study published in the journal MedComm – Biomaterials and Applications, led by Dr. Xiaojing Wang from the Department of Oral Implantology at The Affiliated Hospital of Qingdao University, focuses on addressing tooth loss, ...
Mar 29, 2024
0
2
A study by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests that injecting engineered dendritic cells directly into cancerous lung tumors can help promote a stronger immune response, causing more ...
Mar 26, 2024
0
0
Using bovine bones obtained from cows, a group of scientists say they have developed novel bone graft material that can help fractured and injured bones to grow with minimum adverse body reactions.
Mar 26, 2024
0
31
For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-specific antigen, in addition to the wild-type ...
Mar 23, 2024
0
2
Retear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue engineering have demonstrated ...
Mar 18, 2024
0
0
Research from Edith Cowan University (ECU) has found that intrauterine exposure to diabetes could be a crucial factor in the mental and psychomotor development of children, particularly those younger than 12 months.
Mar 13, 2024
0
11
Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain ...
Mar 13, 2024
0
89
